It is not clear which cellular mechanism induced by gilteritinib leads to the induction of senescence, nonetheless, this study supports our finding that the amino acid transporter SNAT1 is connected to the repression of senescence in tumor cells. Here, SLC38A1 is linked to neoplasm.